Company Name: Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of drugs designed to modulate the activity of transcription factors. The company’s developmental pipeline includes product candidates in a several areas including cardiovascular, immune-oncology, ophthalmology and rare diseases.
Ticker Symbol: RETA (NASDAQ)
Company Website: http://reatapharma.com
Headquarters: Irving, Texas